The Japan Society for Menopause and Women’s Health
Journal of the Japan Society for Menopause and Women’s Health
| V0l.18-1 | V0l.18-2 | V0l.19-1 | vol.19-2 | vol.20-1 |
| vol.20-2 | vol.20-3 | vol.21-1 | vol.21-2 | vol.22-1 |
V0l.18-2
(ORIGINAL)
State of the mental health of the menopausal women in the general population.
Kyoichi GOTO1）2）, Miyoko KUME2）
1）Environment Research Center, Airport Environment Improvement Foundation
2）School of Nursing, Tokyo Women’s Medical University
<Summery>
The aim of this study was to examine state of the mental health of the menopausal women in the general population. A self-report questionnaire survey was conducts general population inTokyo and Fukuoka City
(ORIGINAL)
Availability of hormone replacement therapy for menopausal depressive mood
TAKAMINE SATOKO, OBAYASHI SATOSHI, KATO SEIKO, AKIYOSHI MIHOKO, TERAUCHI KAZUMASA, KUBOTA TOSHIRO
Department of Comprehensive Reproductive Medicine,Tokyo Medical and Dental University Medical Hospital
In addition to an endocrinological factor, a social factor, an environmental factor and the psychological factor crosswire to the cause of the menopausal symptoms including the autonomic dystonia. Furthermore, women who appear for the state of psychoneurosis are increasing in recent years in middle and advanced age which is regarded as a reason of the decreased QOL. The purpose of this study is to analyze symptomatic transition of depressive mood in peri-menopausal women by using menopausal QOL score and to verify HRT utility on this mood disorder.
Materials and methods
Investigated objects were 299 peri-menopausal women who had medical examination in our department for 12 years from November 1995 to October 2006. These objects were not having any medication before, and cases who simultaneously took both HRT and psychotropic drug were excluded in this study. Yearly transition of depressive mood and QOL scores were analyzed and compared with or without HRT / psychotropic, retrospectively.
Results
Mean age of the objects was 52.4±0.37 (Mean ± SEM) years and 97 women (32.4 %) had a depressive mood at the 1st visit. After 1 year follow-up, 39 women out of 97 were taking hormone replacement therapy and 32 women (82.1 %) showed no evidence of depression. This improved ratio was statistically higher than that of the medication free group. Analysis on QOL scores also revealed an improved quality after 6 months and 1 year, which was superior in HRT and psychotropic used groups.
Conclusion
HRT might have a possibility to improve depressive mood, resulting in advanced QOL in peri-menopausal women.
(ORIGINAL)
Analyses of consultation rate and factors related to consultation behavior for menopausal women with high SMI scores
Nobuko OZEK1) Hideki MIZUNUMA2) Yutaka HASUO3) Keiko OI1)Megumi SATO1) Makiko YAMAMOTO1) Ayano KATAYAMA1)
Kimiko YATABE1)
1) Aomori University of Health and Welfare、Department of Health Sciences
2) Department of Obstetrics and Gynecology,Hirosaki University Graduate School
3) Hirosaki Women’s Clinic
<Summery>
Objectives : This study examined the consultation rate and factors related to consultation behavior of women who scored SMI≧51 (henceforth the ‘high risk group’).
Methods : This was a cross-sectional study using anonymous questionnaires, including SMI and GHQ30. Using convenience sampling, 1100 questionnaires were distributed to women aged between 45 and 55. The collection rate was 46.5% and 459 questionnaires were subjected to statistical analyses. Women who scored SMI≧51 and those who scored SMI≦50 (the counter group) were compared in relation to their consultation rate and factors related to consultation behavior.
Findings and Conclusion : Nineteen per cent of respondents were in the high risk group. Among these, 12.5% had not yet seen a gynecologist. The high risk group showed a correlation with the following factors: ‘lower educational background’, ‘dissatisfaction with life’, ‘dissatisfaction with husband’, ‘higher GHQ score’, ’putting up with symptoms’ and ’using Kampo and over-the-counter supplements’. These factors which encouraged positive consultation behavior were ‘SMI’ and 'doctor’s advice’. Systems which allow these women to get holistic information and screening need to be set up to encourage women who need treatment to see a gynecologist as soon as possible.
(ORIGINAL)
The relation of serum uric acid and aging in perimenopausal women
Akira OISHI, Yoshiko MOCHIZUKI, Yuki MURAKOSHI, Takeyoshi OHKURA, Noriyuki INABA
Department of Obstetrics and Gynecology,Dokkyo Medical University
<Summery>
Objective: Hyperuricemia among postmenopausal women has been associated with metabolic syndrome and cardiovascular disease. However, there was no evidence to support a causal relation. The aim of this study was designed to investigate variations of serum uric acid during perimenopausal period and the effect of Estrogen Replacement Therapy (ERT) on serum concentration of uric acid.
Method: We assessed 157 perimenopausal women. We classified with 4 groups, regular menstruating women, after 0 to 2 years postmenopausal women, after 3 to 5 years postmenopausal women and over 6 years postmenopausal women. Serum uric acid and serum lipid profiles were measured in each group. Furtheremore, we measured serum concentrations of uric acid at base line, 12 months and 24 months receiving ERT. In the control group, the same parameters were measured without ERT.
Result: Serum uric acid was slightly higher among postmenopausal women than among premenopausal women(4.3mg/dl vs 4.0mg/dl). Serum lipid profiles, triglyceride correlated with serum uric acid. ERT reduced serum uric acid in post surgical menopausal women. Serum uric acid levels were more reduced among obesity group than normal body mass index (BMI) group in ERT.
Conclusion: It was suggested that the management of uric acid may have protective effect on metabolic syndrome in postmenopausal women.
State of the mental health of the menopausal women in the general population.
Kyoichi GOTO1）2）, Miyoko KUME2）
1）Environment Research Center, Airport Environment Improvement Foundation
2）School of Nursing, Tokyo Women’s Medical University
<Summery>
The aim of this study was to examine state of the mental health of the menopausal women in the general population. A self-report questionnaire survey was conducts general population in
(ORIGINAL)
Availability of hormone replacement therapy for menopausal depressive mood
TAKAMINE SATOKO, OBAYASHI SATOSHI, KATO SEIKO, AKIYOSHI MIHOKO, TERAUCHI KAZUMASA, KUBOTA TOSHIRO
Department of Comprehensive Reproductive Medicine,
In addition to an endocrinological factor, a social factor, an environmental factor and the psychological factor crosswire to the cause of the menopausal symptoms including the autonomic dystonia. Furthermore, women who appear for the state of psychoneurosis are increasing in recent years in middle and advanced age which is regarded as a reason of the decreased QOL. The purpose of this study is to analyze symptomatic transition of depressive mood in peri-menopausal women by using menopausal QOL score and to verify HRT utility on this mood disorder.
Materials and methods
Investigated objects were 299 peri-menopausal women who had medical examination in our department for 12 years from November 1995 to October 2006. These objects were not having any medication before, and cases who simultaneously took both HRT and psychotropic drug were excluded in this study. Yearly transition of depressive mood and QOL scores were analyzed and compared with or without HRT / psychotropic, retrospectively.
Results
Mean age of the objects was 52.4±0.37 (Mean ± SEM) years and 97 women (32.4 %) had a depressive mood at the 1st visit. After 1 year follow-up, 39 women out of 97 were taking hormone replacement therapy and 32 women (82.1 %) showed no evidence of depression. This improved ratio was statistically higher than that of the medication free group. Analysis on QOL scores also revealed an improved quality after 6 months and 1 year, which was superior in HRT and psychotropic used groups.
Conclusion
HRT might have a possibility to improve depressive mood, resulting in advanced QOL in peri-menopausal women.
(ORIGINAL)
Analyses of consultation rate and factors related to consultation behavior for menopausal women with high SMI scores
Nobuko OZEK1) Hideki MIZUNUMA2) Yutaka HASUO3) Keiko OI1)Megumi SATO1) Makiko YAMAMOTO1) Ayano KATAYAMA1)
Kimiko YATABE1)
1) Aomori University of Health and Welfare、Department of Health Sciences
2) Department of Obstetrics and Gynecology,
3) Hirosaki Women’s Clinic
<Summery>
Objectives : This study examined the consultation rate and factors related to consultation behavior of women who scored SMI≧51 (henceforth the ‘high risk group’).
Methods : This was a cross-sectional study using anonymous questionnaires, including SMI and GHQ30. Using convenience sampling, 1100 questionnaires were distributed to women aged between 45 and 55. The collection rate was 46.5% and 459 questionnaires were subjected to statistical analyses. Women who scored SMI≧51 and those who scored SMI≦50 (the counter group) were compared in relation to their consultation rate and factors related to consultation behavior.
Findings and Conclusion : Nineteen per cent of respondents were in the high risk group. Among these, 12.5% had not yet seen a gynecologist. The high risk group showed a correlation with the following factors: ‘lower educational background’, ‘dissatisfaction with life’, ‘dissatisfaction with husband’, ‘higher GHQ score’, ’putting up with symptoms’ and ’using Kampo and over-the-counter supplements’. These factors which encouraged positive consultation behavior were ‘SMI’ and 'doctor’s advice’. Systems which allow these women to get holistic information and screening need to be set up to encourage women who need treatment to see a gynecologist as soon as possible.
(ORIGINAL)
The relation of serum uric acid and aging in perimenopausal women
Akira OISHI, Yoshiko MOCHIZUKI, Yuki MURAKOSHI, Takeyoshi OHKURA, Noriyuki INABA
Department of Obstetrics and Gynecology,
<Summery>
Objective: Hyperuricemia among postmenopausal women has been associated with metabolic syndrome and cardiovascular disease. However, there was no evidence to support a causal relation. The aim of this study was designed to investigate variations of serum uric acid during perimenopausal period and the effect of Estrogen Replacement Therapy (ERT) on serum concentration of uric acid.
Method: We assessed 157 perimenopausal women. We classified with 4 groups, regular menstruating women, after 0 to 2 years postmenopausal women, after 3 to 5 years postmenopausal women and over 6 years postmenopausal women. Serum uric acid and serum lipid profiles were measured in each group. Furtheremore, we measured serum concentrations of uric acid at base line, 12 months and 24 months receiving ERT. In the control group, the same parameters were measured without ERT.
Result: Serum uric acid was slightly higher among postmenopausal women than among premenopausal women(4.3mg/dl vs 4.0mg/dl). Serum lipid profiles, triglyceride correlated with serum uric acid. ERT reduced serum uric acid in post surgical menopausal women. Serum uric acid levels were more reduced among obesity group than normal body mass index (BMI) group in ERT.
Conclusion: It was suggested that the management of uric acid may have protective effect on metabolic syndrome in postmenopausal women.